191 related articles for article (PubMed ID: 11751014)
21. Synthesis, biological evaluation and molecular modeling of substituted 2-aminobenzimidazoles as novel inhibitors of acetylcholinesterase and butyrylcholinesterase.
Zhu J; Wu CF; Li X; Wu GS; Xie S; Hu QN; Deng Z; Zhu MX; Luo HR; Hong X
Bioorg Med Chem; 2013 Jul; 21(14):4218-24. PubMed ID: 23719283
[TBL] [Abstract][Full Text] [Related]
22. Reciprocal regulation of acetylcholinesterase and butyrylcholinesterase in mammalian skeletal muscle.
Berman HA; Decker MM; Jo S
Dev Biol; 1987 Mar; 120(1):154-61. PubMed ID: 3817286
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase.
Toutant JP; Massoulié J; Bon S
J Neurochem; 1985 Feb; 44(2):580-92. PubMed ID: 2578181
[TBL] [Abstract][Full Text] [Related]
24. Production and characterization of separate monoclonal antibodies to human acetylcholinesterase and butyrylcholinesterase.
Brimijoin S; Mintz KP; Alley MC
Mol Pharmacol; 1983 Nov; 24(3):513-20. PubMed ID: 6195517
[TBL] [Abstract][Full Text] [Related]
25. IN VITRO ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORY POTENTIALS OF JATROPHA GOSSYPIFOLIA PLANT EXTRACTS.
Saleem H; Ahmad I; Shahid MN; Gill MS; Nadeem MF; Mahmood W; Rashid I
Acta Pol Pharm; 2016; 73(2):419-23. PubMed ID: 27180434
[TBL] [Abstract][Full Text] [Related]
26. Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay.
Brimijoin S; Hammond P
J Neurochem; 1988 Oct; 51(4):1227-31. PubMed ID: 2901462
[TBL] [Abstract][Full Text] [Related]
27. Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat.
Edwards JA; Brimijoin S
J Neurochem; 1982 May; 38(5):1393-403. PubMed ID: 7062057
[TBL] [Abstract][Full Text] [Related]
28. Anti-epitope antibody, a novel site-directed antibody against human acetylcholinesterase.
Zhang XM; Liu G; Sun MJ
Acta Pharmacol Sin; 2004 Apr; 25(4):431-5. PubMed ID: 15066208
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
30. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
31. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
32. Immunochemistry of mammalian cholinesterases.
Brimijoin S; Rakonczay Z; Mintz K
Fed Proc; 1986 Dec; 45(13):2960-4. PubMed ID: 2430838
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
34. Synthetic antigenic decapeptides of human brain acetylcholinesterase cross-immunoreact with peptide-specific antibodies against Torpediniformes narcine timlei acetylcholinesterase.
Zhang XM; Liu G; Sun MJ
Brain Res; 2001 Mar; 895(1-2):277-82. PubMed ID: 11259791
[TBL] [Abstract][Full Text] [Related]
35. Screening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Wszelaki N; Kuciun A; Kiss AK
Acta Pharm; 2010 Mar; 60(1):119-28. PubMed ID: 20228046
[TBL] [Abstract][Full Text] [Related]
36. Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2(dy) mice.
Gómez JL; García-Ayllón MS; Campoy FJ; Vidal CJ
J Neurosci Res; 2000 Oct; 62(1):134-45. PubMed ID: 11002295
[TBL] [Abstract][Full Text] [Related]
37. Inhibition and recovery of maternal and fetal cholinesterase enzymes following a single oral dose of chlorpyrifos in rats.
Ashry KM; Abu-Qare AW; Saleem FR; Hussein YA; Hamza SM; Kishk AM; Abou-Donia MB
Arch Toxicol; 2002 Feb; 76(1):30-9. PubMed ID: 11875622
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
Feng B; Li X; Xia J; Wu S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
[TBL] [Abstract][Full Text] [Related]
39. Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group.
Gao XH; Zhou C; Liu HR; Liu LB; Tang JJ; Xia XH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):146-152. PubMed ID: 27801600
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]